title: Eltrombopag: Investigation of Previously Reported Serum Discoloration and Negative Interference on a Total Bilirubin Diazo Method.
authors.affiliation: Clinical Pathology Department of Safety Assessment, GlaxoSmithKline, King of Prussia, Pennsylvania.
authors.forename: David F
authors.initials: DF
authors.lastname: Adams
authors.affiliation: Clinical Pathology Department of Safety Assessment, GlaxoSmithKline, King of Prussia, Pennsylvania.
authors.forename: Teresa S
authors.initials: TS
authors.lastname: Sellers
mesh_terms: D000328:Adult; D001391:Azo Compounds / Q000737:chemistry; D001565:Benzoates / Q000009:adverse effects* / Q000097:blood / Q000737:chemistry / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood*; D003116:Color; D004396:Coloring Agents / Q000737:chemistry; D003937:Diagnosis, Differential; D006397:Hematinics / Q000009:adverse effects* / Q000097:blood / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects* / Q000097:blood / Q000737:chemistry / Q000627:therapeutic use; D006932:Hyperbilirubinemia / Q000097:blood / Q000175:diagnosis / Q000209:etiology; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D009994:Osmolar Concentration; D011720:Pyrazoles / Q000009:adverse effects* / Q000097:blood / Q000737:chemistry / Q000627:therapeutic use; D053628:Receptors, Thrombopoietin / Q000819:agonists* / Q000378:metabolism; D015203:Reproducibility of Results; D044967:Serum / Q000737:chemistry; D013053:Spectrophotometry; D013921:Thrombocytopenia / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control
chemical_list: D001391:Azo Compounds; D001565:Benzoates; D004396:Coloring Agents; D006397:Hematinics; D006834:Hydrazines; D011720:Pyrazoles; D053628:Receptors, Thrombopoietin; D001663:Bilirubin; C520809:eltrombopag